Large-scale testing (Phase 3)Study completedNCT02216552
What this trial is testing
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
Who this might be right for
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
University of Manitoba 10